Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
7 drugs for “Generalized Myasthenia Gravis”
Approved 2
Filed 1
- CemdisiranREGENERON PHARMACEUTICALS, INC.Generalized myasthenia gravis (gMG)
Phase 3 3
- EfgartigimodARGENX SEGeneralized Myasthenia Gravis
- IMVT-1402Immunovant, Inc.Generalized Myasthenia Gravis
- TelitaciceptVor Biopharma Inc.Generalized Myasthenia Gravis
Phase 2/3 1
- KYV-101Kyverna Therapeutics, Inc.Generalized Myasthenia Gravis
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.